Renaissance Capital logo

Social Capital Suvretta Holdings IV Priced, Nasdaq: DNAD

Fourth blank check company formed by Chamath Palihapitiya and Kishen Mehta targeting the biotech sector (liquidated).

Industry: SPAC

First Day Return: +1.0%

Industry: SPAC

We are a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. To date, we have not engaged in any operations or generated any revenues. Our only activities since inception have been organizational activities and those necessary to prepare for this offering. Following this offering, we will not generate any operating revenues until after completion of our initial business combination. While we may pursue an initial business combination target in any subsector within the biotechnology industry, or in any other industry, we intend to focus on immunology.
more less
IPO Data
IPO File Date 06/02/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 22.0
Deal Size ($mm) $220
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/29/2021
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $220
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Henderson, NV, United States
Founded 2021
Employees at IPO 4
Website socialcapitalsuvrettaholdings.com/dnad

Social Capital Suvretta Holdings IV (DNAD) Performance